Oregon Public Employees Retirement Fund’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3M Buy
93,152
+700
+0.8% +$20.7K 0.04% 374
2026
Q1
$2.56M Buy
92,452
+5,300
+6% +$136K 0.03% 419
2025
Q4
$1.89M Buy
87,152
+500
+0.6% +$9.87K 0.02% 540
2025
Q3
$1.31M Buy
86,652
+1,019
+1% +$12.6K 0.02% 689
2025
Q2
$965K Buy
85,633
+100
+0.1% +$1.08K 0.02% 802
2025
Q1
$863K Sell
85,533
-1,900
-2% -$20.5K 0.02% 848
2024
Q4
$1.03M Sell
87,433
-867
-1% -$10.3K 0.02% 786
2024
Q3
$1.02M Buy
88,300
+18,000
+26% +$205K 0.02% 795
2024
Q2
$743K Sell
70,300
-16,000
-19% -$175K 0.01% 911
2024
Q1
$910K Buy
+86,300
New +$931K 0.02% 871

Other funds holding ROIV

Oregon Public Employees Retirement Fund's ROIV Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Roivant Sciences (ROIV) stake by 0.76% in Q2 2026, buying an estimated $20.7K and bringing the position to 93,152 shares worth $3.3M. The position accounts for 0.04% of the portfolio, ranked #374.

Oregon Public Employees Retirement Fund first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 93,152 shares of Roivant Sciences worth $3.3M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 700 Roivant Sciences shares in Q2 2026, an estimated $20.7K.
  • Roivant Sciences made up 0.04% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #374 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.